What's Your Diagnosis?

Gastrointestinal Symptoms and Lactic Acidosis in a Chronic Marijuana User

Author and Disclosure Information

 

References

This patient was diagnosed with gastrointestinal beriberi. Because of her dietary changes, lactic acidosis, and bradycardia, thiamine deficiency was suspected after ruling out other possibilities on the differential diagnosis (Table). The patient’s symptoms resolved after administration of high-dose IV thiamine 500 mg 3 times daily for 4 days. Her white blood cell count and lactic acid level normalized. Unfortunately, thiamine levels were not obtained for the patient before treatment was initiated. After administration of IV thiamine, her plasma thiamine level was > 1,200 (normal range, 8-30) nmol/L.

Differential Diagnosis for Nausea, Vomiting, and Epigastric Pain table

Her differential diagnosis included infectious etiology. Given her leukocytosis and lactic acidosis, vancomycin and piperacillin/tazobactam were started on admission. One day later, her leukocytosis count doubled to 20.7×109 cells/L. However, after 48 hours of negative blood cultures, antibiotics were discontinued.

Small bowel obstruction was suspected due to the patient’s history of abdominal surgery but was ruled out with CT imaging. Similarly, pancreatitis was ruled out based on negative CT imaging and the patient’s normal lipase level. Gastroparesis also was considered because of the patient’s history of hypothyroidism, tobacco use, and her prior gastric-emptying study. The patient was treated for gastroparesis with a course of metoclopramide and erythromycin without improvement in symptoms. Additionally, gastroparesis would not explain the patient’s leukocytosis.

Cannabinoid hyperemesis syndrome (CHS) was suspected because the patient’s symptoms improved with cannabis discontinuation and hot showers.1 In chronic users, however, tetrahydrocannabinol levels have a half-life of 5 to 13 days.2 Although lactic acidosis and leukocytosis have been previously reported with cannabis use, it is unlikely that the patient would have such significant improvement within the first 4 days after discontinuation.1,3,4 Although the patient had many psychiatric comorbidities with previous hospitalizations describing concern for somatization disorder, her leukocytosis and elevated lactic acid levels were suggestive of an organic rather than a psychiatric etiology of her symptoms.

Recommended Reading

Naltrexone cuts hospitalization, deaths in alcohol use disorder
Federal Practitioner
Biden administration nixes buprenorphine waiver, docs disappointed
Federal Practitioner
Opioid-related deaths lower in counties with active cannabis dispensaries
Federal Practitioner
Cannabis tied to self-harm, death in youth with mood disorders
Federal Practitioner
Minimizing Opioids After Joint Operation: Protocol to Decrease Postoperative Opioid Use After Primary Total Knee Arthroplasty
Federal Practitioner
Vaccine may blunt effects of deadly synthetic opioids
Federal Practitioner
Fauci worries about possible post–COVID-19 ‘mental health pandemic’
Federal Practitioner
Buprenorphine for OUD may also mitigate risk with concomitant benzo, Z-drug use
Federal Practitioner
THC persists in breast milk 6 weeks after quitting cannabis
Federal Practitioner
Black nonsmokers still at high risk for secondhand smoke exposure
Federal Practitioner

Related Articles